谷歌浏览器插件
订阅小程序
在清言上使用

Real‐world Effectiveness and Persistence of Golimumab As Second‐line Anti‐tnfα Drug in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis Patients in Italy: GO‐BEYOND, a 12‐month Prospective Observational Study

International journal of rheumatic diseases(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要